Altogether, these data indicated that the in situ CRC with OXA resistance exhibited a serial of increased stem-like traits accompanied by the abnormal activation of TOX3-WDR5/ABCG2 signaling pathway. This evidence concerns the gene WDR5 and colorectal carcinoma.